Action Eurofins Scientific - ERF

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

48,64

Prix Achat

48,20

Prix Vente

49,60

Volume échangé

439 699

48,22 Fourchette du Jour 49,96

39,47 Plage de 52 semaines 62,10

Cap du marché

9,387B

Clôture Veille

49,22

Ouverture

49,80

Dernière Transaction

162

48.64

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

427 319

Actions en circulation

192 981 183

Rendement du Dividende

1.03%

Ratio Cours sur Bénéfices

23,10

Bénéfice par action (BPA)

2,11

Chiffre d'affairess

6,97B

Bénéfice net

406,4M

Secteur

Testing Laboratories

Industrie

Testing Laboratories

Site Web

www.eurofins.com

Siège social

Grand Duche Du, Lux

Fondé

Eurofins Scientific SE est coté dans le secteur Testing Laboratories de la Euronext avec le ticker ERF. Le dernier cours de clôture d'Eurofins Scientific était de 49,22 €. Au cours de la dernière année, les actions de Eurofins Scientific ont été négociées dans une fourchette de prix de 39,47 € à 62,10 €.

Eurofins Scientific compte actuellement 192 981 183 actions en circulation. La capitalisation boursière d'Eurofins Scientific est de 9,50 € milliard. Eurofins Scientific a un ratio cours/bénéfice (ratio PE) de 23.10.

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in...

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and...

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de...

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs...

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé...

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and...

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-2.1	-4.13874655104	50.74	51.24	48.22	420849	49.72386967	DE
4	-0.36	-0.734693877551	49	52.98	48.22	474148	50.55461821	DE
12	-1.04	-2.09339774557	49.68	52.98	45.56	427319	49.75852184	DE
26	-8.42	-14.7563967753	57.06	57.68	44.52	402685	49.09263398	DE
52	-10.06	-17.1379897785	58.7	62.1	39.47	402183	50.90278063	DE
156	-41.58	-46.0873420528	90.22	100.5	39.47	389631	59.77108357	DE
260	-384.66	-88.774521117	433.3	754	39.47	334422	76.73995134	DE

ERF - Frequently Asked Questions (FAQ)

What is the current Eurofins Scientific share price?

The current share price of Eurofins Scientific is 48,64 €

How many Eurofins Scientific shares are in issue?

Eurofins Scientific has 192 981 183 shares in issue

What is the market cap of Eurofins Scientific?

The market capitalisation of Eurofins Scientific is EUR 9,5B

What is the 1 year trading range for Eurofins Scientific share price?

Eurofins Scientific has traded in the range of 39,47 € to 62,10 € during the past year

What is the PE ratio of Eurofins Scientific?

The price to earnings ratio of Eurofins Scientific is 23,1

What is the cash to sales ratio of Eurofins Scientific?

The cash to sales ratio of Eurofins Scientific is 1,35

What is the reporting currency for Eurofins Scientific?

Eurofins Scientific reports financial results in EUR

What is the latest annual turnover for Eurofins Scientific?

The latest annual turnover of Eurofins Scientific is EUR 6,97B

What is the latest annual profit for Eurofins Scientific?

The latest annual profit of Eurofins Scientific is EUR 406,4M

What is the registered address of Eurofins Scientific?

The registered address for Eurofins Scientific is 23 VAL FLEURI, GRAND DUCHE DU, L-1526

What is the Eurofins Scientific website address?

The website address for Eurofins Scientific is www.eurofins.com

Which industry sector does Eurofins Scientific operate in?

Eurofins Scientific operates in the TESTING LABORATORIES sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALBPKBroadpeak SA	1,44 € (32,72%)	17,95k
MLPRXParx Materials NV	0,148 € (28,70%)	100
ALMDTMedian Technologies	3,035 € (21,40%)	465,86k
MLNMAMiguet Et Associes	0,188 € (17,50%)	10k
MLOCTOctopus Biosafety	0,118 € (16,83%)	6k
ALMKTMauna Kea Technologies SA	0,112 € (-33,73%)	2,29M
ALMCPMcphy Energy	0,602 € (-30,32%)	770,36k
DMSBSDiagnostic Medical Systems	0,0045 € (-25,00%)	7,61k
ALVERVergnet	0,0009 € (-18,18%)	788,89M
ALALOAcheterLouerFR	0,0009 € (-18,18%)	258,96M
ALVERVergnet	0,0009 € (-18,18%)	788,89M
ATOAtos SE	0,0039 € (0,00%)	339,28M
ALALOAcheterLouerFR	0,0009 € (-18,18%)	258,96M
ALCYBCybergun	0,0002 € (0,00%)	181,22M
BCPBanco Comercial Portugues SA	0,5668 € (1,72%)	65,21M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eurofins Scientific SE (ERF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Eurofins Scientific SE

ERF Dernières nouvelles

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Eurofins Scientific SE (ERF) Cours

Eurofins Scientific SE (ERF)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Eurofins Scientific SE

ERF Dernières nouvelles

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

ERF - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités